| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Abiomed Inc (F: AIO)
AIO Technical Analysis
5
| As on 12th Jan 2023 AIO STOCK Price closed @ 17.16 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 276.85 & Strong Sell for SHORT-TERM with Stoploss of 291.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AIOSTOCK Price
| Open | 17.12 | Change | Price | % |
| High | 17.20 | 1 Day | 0.16 | 0.94 |
| Low | 16.85 | 1 Week | 1.20 | 7.52 |
| Close | 17.16 | 1 Month | -346.64 | -95.28 |
| Volume | 92348 | 1 Year | -257.74 | -93.76 |
| 52 Week High 382.40 | 52 Week Low 15.96 | ||||
F Germany Most Active Stocks
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TOE | 0.02 | 0.00% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| AIO Daily Charts |
AIO Intraday Charts |
Whats New @ Bazaartrend |
AIO Free Analysis |
|
|
AIO Important Levels Intraday
| RESISTANCE | 17.83 |
| RESISTANCE | 17.62 |
| RESISTANCE | 17.48 |
| RESISTANCE | 17.35 |
| SUPPORT | 16.97 |
| SUPPORT | 16.84 |
| SUPPORT | 16.70 |
| SUPPORT | 16.49 |
AIO Forecast May 2024
| 4th UP Forecast | 88.84 |
| 3rd UP Forecast | 65.85 |
| 2nd UP Forecast | 51.64 |
| 1st UP Forecast | 37.43 |
| 1st DOWN Forecast | -3.11 |
| 2nd DOWN Forecast | -17.32 |
| 3rd DOWN Forecast | -31.53 |
| 4th DOWN Forecast | -54.52 |
AIO Weekly Forecast
| 4th UP Forecast | 67.07 |
| 3rd UP Forecast | 51.06 |
| 2nd UP Forecast | 41.17 |
| 1st UP Forecast | 31.28 |
| 1st DOWN Forecast | 3.04 |
| 2nd DOWN Forecast | -6.85 |
| 3rd DOWN Forecast | -16.74 |
| 4th DOWN Forecast | -32.75 |
AIO Forecast2024
| 4th UP Forecast | 723.44 |
| 3rd UP Forecast | 496.93 |
| 2nd UP Forecast | 356.92 |
| 1st UP Forecast | 216.91 |
| 1st DOWN Forecast | -182.59 |
| 2nd DOWN Forecast | -322.6 |
| 3rd DOWN Forecast | -462.61 |
| 4th DOWN Forecast | -689.12 |
Abiomed Inc ( F Germany Symbol : AIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AIO Business Profile
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the Automated Impella Controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; and Impella BTR, a percutaneous micro heart pump with integrated motors and sensors. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Address: 22 Cherry Hill Drive, Danvers, MA, United States, 01923
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service